Compile Data Set for Download or QSAR
Report error Found 148 Enz. Inhib. hit(s) with all data for entry = 1743
TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337803(2,4-Dioxo-1-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-...)
Affinity DataIC50: 10nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337774(1-[3,5-Dichloro-4-(2-oxoimidazolidin-1-yl)phenyl]-...)
Affinity DataIC50: 11nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337767(1-[3-Chloro-4-(2-oxoimidazolidin-1-yl)phenyl]-3-[2...)
Affinity DataIC50: 12nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337766(1-[3-Chloro-4-(2-oxoimidazolidin-1-yl)phenyl]-3-[2...)
Affinity DataIC50: 13nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337796(1-[2-Fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2...)
Affinity DataIC50: 13nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337759(1-[3-Chloro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-3...)
Affinity DataIC50: 16nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337773(3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-[3,5-dich...)
Affinity DataIC50: 16nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337758(1-[3-Chloro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-3...)
Affinity DataIC50: 17nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337793(2,4-Dioxo-1-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-...)
Affinity DataIC50: 17nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337755(3-[2-Chloro-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...)
Affinity DataIC50: 18nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337788(1-(3,4-Dimethoxyphenyl)-2,4-dioxo-3-[4-(trifluorom...)
Affinity DataIC50: 18nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337770(3-[2,3-Bis(trifluoromethyl)benzyl]-2,4-dioxo-1-[4-...)
Affinity DataIC50: 19nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337690(3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...)
Affinity DataIC50: 21nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337720(3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...)
Affinity DataIC50: 21nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337802(Ethyl 2,4-dioxo-1-[4-(2-oxo-1,3-oxazolidin-3-yl)ph...)
Affinity DataIC50: 22nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337683(1-[3-Fluoro-4-(2-oxoimidazolidin-1-yl)phenyl]-3-[2...)
Affinity DataIC50: 24nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337789(3-[2,3-Bis(trifluoromethyl)benzyl]-1-(3,4-dimethox...)
Affinity DataIC50: 24nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337708(3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...)
Affinity DataIC50: 28nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337761(3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-[3-methyl...)
Affinity DataIC50: 31nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337764(1-[2-Fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-3...)
Affinity DataIC50: 31nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337805(3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...)
Affinity DataIC50: 31nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337765(3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-[3,5-dich...)
Affinity DataIC50: 37nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337739(Ethyl 3-[2-chloro-3-(trifluoromethyl)benzyl]-2,4-d...)
Affinity DataIC50: 38nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337760(1-[3-Methyl-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-3...)
Affinity DataIC50: 38nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337801(3-(5-Chloro-1,2,3,4-tetrahydronaphthalen-1-yl)-2,4...)
Affinity DataIC50: 43nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337676(3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...)
Affinity DataIC50: 45nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337747(Ethyl 3-[2-chloro-3-(trifluoromethyl)benzyl]-1-[3,...)
Affinity DataIC50: 49nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337709(3-(3-Chloro-2-nitrobenzyl)-2,4-dioxo-1-[4-(2-oxo-1...)
Affinity DataIC50: 54nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337748(Ethyl 1-[3,5-dichloro-4-(2-oxoimidazolidin-1-yl)ph...)
Affinity DataIC50: 54nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337798(2,4-Dioxo-1-[4-(2-oxoimidazolidin-1-yl)phenyl]-3-[...)
Affinity DataIC50: 54nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337762(3-(2,3-Dichlorobenzyl)-1-[2-fluoro-4-(2-oxo-1,3-ox...)
Affinity DataIC50: 55nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337694(1-(3,4-Dimethoxyphenyl)-3-[2-methyl-3-(trifluorome...)
Affinity DataIC50: 56nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337791(3-(4-Chloro-2,3-dihydro-1H-inden-1-yl)-2,4-dioxo-1...)
Affinity DataIC50: 56nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337763(3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-[2-fluoro...)
Affinity DataIC50: 58nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337769(3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-[2-methyl...)
Affinity DataIC50: 58nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337689(3-[3-Fluoro-2-(trifluoromethyl)benzyl]-2,4-dioxo-1...)
Affinity DataIC50: 59nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337757(3-[2-Chloro-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...)
Affinity DataIC50: 60nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337768(1-[2-Methyl-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-3...)
Affinity DataIC50: 60nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337699(3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...)
Affinity DataIC50: 61nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337795(Ethyl 1-[2-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phe...)
Affinity DataIC50: 62nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337785(3-(3-Chloro-2-methylbenzyl)-2,4-dioxo-1-[4-(2-oxo-...)
Affinity DataIC50: 63nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337790(3-(4-Chloro-2,3-dihydro-1H-inden-1-yl)-1-(3,4-dime...)
Affinity DataIC50: 64nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337794(1-[3-Chloro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2...)
Affinity DataIC50: 66nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337682(1-[3-Fluoro-4-(2-oxoimidazolidin-1-yl)phenyl]-3-(2...)
Affinity DataIC50: 67nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337685(3-(2,3-Dichlorobenzyl)-2,4-dioxo-1-[4-(2-oxo-2,3-d...)
Affinity DataIC50: 68nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337777(3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...)
Affinity DataIC50: 71nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337743(Ethyl 1-[2-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phe...)
Affinity DataIC50: 72nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337688(3-(2-Methyl-3-nitrobenzyl)-2,4-dioxo-1-[4-(2-oxo-1...)
Affinity DataIC50: 74nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337734(3-[(3-Chloro-4-methyl-2-thienyl)methyl]-2,4-dioxo-...)
Affinity DataIC50: 74nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetChymase(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM337742(Ethyl 1-[3-chloro-4-(2-oxo-1,3-oxazolidin-3-yl)phe...)
Affinity DataIC50: 76nMAssay Description:The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 148 total ) | Next | Last >>
Jump to: